EAM
BIVV

Edge Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Edge Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$8.51M Buy
+156,193
New +$7.69M 0.06% 211

Other funds holding BIVV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
SIG
Senator Investment Group New York $2.74B AUM 55.95% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Edge Asset Management's BIVV Position: Q1 2017 in Review

Edge Asset Management opened a new position in Bioverativ Inc. Common Stock (BIVV) in Q1 2017: 156,193 shares worth $8.51M. The stake represents 0.06% of the portfolio and ranks #211 among its holdings.

467 funds tracked by Wall St. Rank hold BIVV as of Q1 2017.

  • Edge Asset Management held 156,193 shares of Bioverativ Inc. Common Stock worth $8.51M as of Q1 2017.
  • Bioverativ Inc. Common Stock was a new Edge Asset Management position in Q1 2017.
  • Bioverativ Inc. Common Stock made up 0.06% of Edge Asset Management's portfolio in Q1 2017, its #211 holding.
  • 467 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2017.

Based on Edge Asset Management's 13F filing for Q1 2017, filed 11 May 2017.